CHMP opinions diverging from EMA scientific advice
This article was originally published in Scrip
Executive Summary
The European Medicines Agency is taking steps to address the "possibility of decreasing compliance" between its scientific advice and the final opinions of its human drugs evaluation committee, the CHMP.